ATP1A1 and esophageal squamous cell carcinoma: Our research established that GPR37 interacts with ATP1A1 to promote its ubiquitinated degradation, which in turn inhibits AKT phosphorylation and then suppresses ESCC proliferation, migration, and DNA damage repair processes.